These findings highlight the crucial role of the BRD4/MAP2K7/PGF signaling axis in cellular senescence and ECM regulation, suggesting that BRD4 represents a promising therapeutic target for IDD. This evidence concerns the gene MAP2K7 and intervertebral disk degenerative disorder.